The prevention of schizophrenia

International Review of Psychiatry

Volumn 19, Issue 6, 2007, Pages 633-646

  Yung, A R ^a,b   Killackey, E ^a,b   Hetrick, S E ^a,b   Parker, A G ^a,b   Schultze Lutter, F ^c   Klosterkoetter, J ^c   Purcell, R ^a,b   McGorry, P D ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ORYGEN RESEARCH CENTRE   (Australia)

^c UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

OLANZAPINE;

CANNABIS ADDICTION; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DRUG USE; HIGH RISK POPULATION; HUMAN; LOW DRUG DOSE; MENTAL DISEASE; MENTAL HEALTH CARE; NEUROPROTECTION; PREVENTIVE MEDICINE; PRIORITY JOURNAL; PSYCHOSIS; PSYCHOSOCIAL CARE; REVIEW; RISK FACTOR; SCHIZOPHRENIA; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 38749094846     PISSN: 09540261     EISSN: 13691627     Source Type: Journal    
DOI: 10.1080/09540260701797803     Document Type: Review

References (154)

1. Adams, W., Kendell, R. E., Hare, E. H., & Munk, J. P. (1993). Epidemiological evidence that maternal influenza contributes to the aetiology of schizophrenia: An analysis of Scottish, English and Danish data. British Journal of Psychiatry, 163, 522-534.
2. Andréasson, S., Allebeck, P., Engström, A., & Rydberg, U. (1987). Cannabis and schizophrenia: A longitudinal study of Swedish conscripts. Lancet, 2(8574), 1483-1486.
3. Aro, S., Aro, H., & Keskimaeki, I. (1995). Socio-economic mobility among patients with schizophrenia or major affective disorder: A 17-year retrospective follow-up. British Journal of Psychiatry, 166, 759-767.
4. Arseneault, L., Cannon, M., Poulton, R., Murray, R., Caspi, A., & Moffitt, T. E. (2002). Cannabis use in adolescence and risk for adult psychosis: Longitudinal prospective study. BMJ, 325, 1212-1213.
5. Bai, O., Wei, Z., Lu, W., Bowen, R., Keegan, D., & Li, X. M. (2002). Protective effects of atypical antipsychotic drugs on PC12 cells after serum withdrawal. Journal of Neuroscience Research, 69(2), 278-283.
6. Bechdolf, A., Ruhrman, S., Wagner, M., Kuhn, K. U., Janssen, B., Bottlender, R. et al. (2005a). Interventions in the initial prodromal states of psychosis in Germany: Concept and recruitment. British Journal of Psychiatry, 187(suppl. 48), s45-48.
7. Bechdolf, A., Veith, V., Schwarzer, D., Schormann, M., Stamm, E., Janssen, B. et al. (2005b). Cognitive-behavioural therapy in the pre-psychotic phase: An exploratory study. Psychiatry Research, 136, 251-55.
8. Bechdolf, A., Wagner, M., Veith, V., Ruhrmann, R., Janssen, B., Bottlender, R. et al. (1992). Multiple-risk cohorts and segmenting risk as solutions to the problem of false positives in risk for the major psychoses. Psychiatry, 55, 370-381.
9. Berger, G. E., Wood, S., & McGorry, P. D. (2003). Incipient neurovulnerability and neuroprotection in early psychosis. Psychopharmacology Bulletin, 37, 79-101.
10. Berger, G., Dell'Olio, M., Amminger, P., Cornblatt, B., Phillips, L., Yung, A. et al. (in press). Neuroprotection in emerging psychotic disorders. Early Intervention in Psychiatry.
11. Birchwood, M., Todd, P., & Jackson, C. (1998). Early intervention in psychosis. The critical period hypothesis. British Journal of Psychiatry, 172(suppl. 33), s53-s59.
12. Bottlender, R., & Moller, H. J. (2003). The impact of the duration of untreated psychosis on short- and long-term outcome in schizophrenia. Current Opinion in Psychiatry, 16(Suppl. 2), S39-S43.
13. Bowers, M. (1965). The onset of psychosis - A diary account. Psychiatry, 28(4), 346-358.
14. Boydell, J., van Os, J., Lambri, M., Castle, D., Allardyce, J., McCreadie, R. G. et al. (2003). Incidence of schizophrenia in south-east London between 1965 and 1997. British Journal of Psychiatry, 182, 45-49.
15. Brown, C. H., & Liao, J. (1999). Principles for designing randomized preventive trials in mental health: An emerging developmental epidemiology paradigm. American Journal of Community Psychology, 27(5), 673-710.
16. Buckley, P. F. (1998). The clinical stigmata of aberrant neurodevelopment in schizophrenia. Journal of Nervous and Mental Disease, 186, 79-86.
17. Chapman, L. J., & Chapman, J. P. (1987). The search for symptoms predictive of schizophrenia. Schizophrenia Bulletin, 13(3), 497-503.
18. Cohen, P., & Cohen, J. (1984). The clinician's illusion. Archives of General Psychiatry, 41(12), 1178-1182.
19. Cornblatt, B., Lencz, T., & Obuchowski, M. (2002). The schizophrenia prodrome: Treatment and high-risk perspectives. Schizophrenia Research, 54, 177-186.
20. Craig, T. K., Garety, P. A., Power, P., Rahaman, N., Colbert, S., Fornells-Ambrojo, M. et al. (2004). The Lambeth Early Onset (LEO) team: Randomised controlled trial of the effectiveness of specialised care for early psychosis. British Medical Journal, 329, 1067-1072.
21. Cuijpers, P. (2003). Examining the effects of prevention programs on the incidence of new cases of mental disorders: The lack of statistical power. American Journal of Psychiatry, 160, 1385-1391.
22. Davidson, M., Reichenberg, A., Rabinowitz, J., Weiser, M., Kaplan, Z., & Mark, M. (1999). Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents. American Journal of Psychiatry, 156, 1328-1335.
23. Docherty, J. P., Van Kammen, D. P., Siris, S. G., & Marder, S. R. (1978). Stages of onset of schizophrenic psychosis. American Journal of Psychiatry, 135(4), 420-426.
24. Done, D. J., Sacker, A., & Crow, T. J. (1994). Childhood antecedents of schizophrenia and affective illness: Intellectual performance at ages 7 and 11. Schizophrenia Research, 11, 96.
25. Done, D. J., Crow, T. J., Johnstone, E. C., & Sacker, A. (1994). Childhood antecedents of schizophrenia and affective illness: Social adjustment at ages 7 and 11. British Medical Journal, 309, 699-703.
26. Donlon, P. T., & Blacker, K. H. (1973). Stages of schizophrenic decompensation and reintegration. Journal of Nervous and Mental Disease, 157, 200-209.
27. Eaton, W. W., Badawi, M., & Melton, B. (1995). Prodromes and precursors: Epidemiologic data for primary prevention of disorders with slow onset. American Journal of Psychiatry, 152, 967-972.
28. Eaton, W., & Harrison, G. (2001). Life chances, life planning, and schizophrenia: A review and interpretation of research on social deprivation. International Journal of Mental Health, 30, 58-81.
29. Edwards, J., Harris, M. G., & Bapat, S. (2005). Developing services for first-episode psychosis and the critical period. British Journal of Psychiatry, 187(suppl. 48), s91-97.
30. Edwards, J., & McGorry, P. D. (2002). Implementing early interventions in psychosis: A guide to establishing early psychosis services. London: Martin Dunitz.
31. Early Psychosis Prevention & Intervention Centre. (1997). EPPIC early psychosis training pack. Melbourne: EPPIC.
32. Faergman, P. (1963). Psychogenic psychoses. London: Butterworth.
33. Fava, G. A., & Kellner, R. (1993). Staging: A neglected dimension in psychiatric classification. Acta Psychiatrica Scandinavica, 87(4), 225-230.
34. Frangou, S., & Murray, R. M. (2000). Schizophrenia, (2nd ed.). London: Martin Dunitz.
35. Friis, S., Vaglum, P., Haahr, U., Johannessen, J. O., Larsen, T. K., Melle, I. et al. (2005). Effect of an early detection programme on duration of untreated psychosis: Part of the Scandinavian TIPS study. British Journal of Psychiatry, 48(Suppl.), s29-s32.
36. Garety, P. A., Craig, T. K., Dunn, G., Fornells-Ambrojo, M., Colbert, S., Rahaman, N. et al. (2006). Specialised care for early psychosis: Symptoms, social functioning and patient satisfaction: Randomised controlled trial. British Journal of Psychiatry, 188, 37-45.
37. Geddes, J., & Lawrie, S. (1995). Obstetric complications and schizophrenia. British Journal of Psychiatry, 167, 786-793.
38. Gleeson, J., Larsen, T. K.,& McGorry, P. D. (2003). Psychological treatment in pre- and early psychosis. Journal of the American Academy of Psychoanalysis and Dynamic Psychiatry, 31, 229-245.
39. Greenfield, S., Strakowski, S., Tohen, M., Batson, S., & Kolbrener, M. (1994). Child abuse in first episode psychosis. British Journal of Psychiatry, 64, 831-834.
40. Gross, G. (1997). The onset of schizophrenia. Schizophrenia Research, 28, 187-198.
41. Gross, G., & Huber, G. (1996). The true onset of schizophrenia in its meaning for the view of the disorder. Neurology, Psychiatry and Brain Research, 4, 93-102.
42. Hafner, H., Maurer, K., Trendler, G., An Der Heiden, W., Schmidt, M., & Konnecke, R. (2005). Schizophrenia and depression: Challenging the paradigm of two separate diseases - a controlled study of schizophrenia, depression and healthy controls. Schizophrenia Research, 77(1), 11-24.
43. Hafner, H., Riecher-Rossler, A., An Der Heiden, W., Maurer, K., Fatkenheuer, B., & Loffler, W. (1993). Generating and testing a causal explanation of the gender difference in age at first onset of schizophrenia. Psychological Medicine, 23(4), 925-940.
44. Haroun, N., Dunn, L., Haroun, A., & Cadenhead, K. S. (2006). Risk and protection in prodromal schizophrenia: Ethical implications for clinical practice and future research. Schizophrenia Bulletin, 32(1), 166-178.
45. Harrigan, S. M., McGorry, P. D., & Krstev, H. (2003). Does treatment delay in first-episode psychosis really matter? Psychological Medicine, 33(1), 97-110.
46. Harris, M. G., Henry, L. P., Harrigan, S. M., Purcell, R., Schwartz, O. S., Farrelly, S. E. et al. (2005). The relationship between duration of untreated psychosis and outcome: An eight-year prospective study. Schizophrenia Research, 79, 85-93.
47. Harris, M. G., Burgess, P. M., Chant, D., Pirkis, J. E., & McGorry, P. D. (2006). Impact of specialised first-episode psychosis treatment on suicide following initial presentation to mental health services: Retrospective cohort study. Schizophrenia Research, 81(Suppl. 1), s307-s308.
48. Heinrichs, D. W., Cohen, B. P., & Carpenter Jr, W. T. (1985). Early insight and the management of schizophrenic decompensation. Journal of Nervous and Mental Disease, 173(3), 133-138.
49. Herz, M. I., & Melville, C. (1980). Relapse in schizophrenia. American Journal of Psychiatry, 137, 801-805.
50. Jackson, C., & Birchwood, M. (1996). Early intervention in psychosis: Opportunities for secondary prevention. British Journal of Psychology, 35, 487-502.
51. Jackson, H. J., McGorry, P. D., Edwards, J., Hulbert, C., Henry, L., Francey, S. et al. (1998). Cognitively oriented psychotherapy for early psychosis (COPE). British Journal of Psychiatry, 172(suppl. 33), s93-s100.
52. Jauch, D. A., & Carpenter Jr, W. T. (1988). Reactive psychosis. I. Does the pre-DSM-III concept define a third psychosis? Journal of Nervous and Mental Disease, 176(2), 72-81.
53. Johannessen, J. O., McGlashan, T. H., Larsen, T. K., Horneland, M., Joa, I. et al. (2001). Early detection strategies for untreated first-episode psychosis. Schizophrenia Research, 51, 39-46.
54. Jolley, S., Garety, P., Carig, T., Dunn, G., White, J., & Aitken, M. (2003). Cognitive therapy in early psychosis: A pilot randomised controlled trial. Behavioural and Cognitive Psychotherapy, 160, 473-478.
55. Jorgensen, P., Nordentoft, M., Abel, M. B., Gouliaev, G., Jeppesen, P., & Kassow, P. (2000). Early detection and assertive community treatment of young psychotics: The OPUS Study. Rationale and design of the trial. Social Psychiatry and Psychiatric Epidemiology, 35(7), 283-287.
56. Jorm, A., Korten, A., Jacomb, P., Christensen, H., Rodgers, B., & Pollitt, P. (1997). 'Mental health literacy': A survey of the public's ability to recognise mental disorders and their beliefs about the effectiveness of treatment. Medical Journal of Australia, 166, 182-186.
57. Kaplan, H. I., Sadock, B. J., & Grebb, J. A. (1994). Kaplan and Sadock's synopsis of psychiatry. Baltimore: Williams & Wilkins.
58. Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62, 593-602.
59. Keys, & Young (1997). Research and consultation among young people on mental health issues, final report. Canberra: Commonwealth Department of Health and Family Services.
60. Killackey, E., & Yung, A. R. (2007). Effectiveness of early intervention in psychosis. Current Opinion in Psychiatry, 20, 121-125.
61. Killackey, E. J., Jackson, H. J., Gleeson, J., Hickie, I. B., & McGorry, P. D. (2006). Exciting career opportunity beacons! Early intervention and vocational rehabilitation in first-episode psychosis: Employing cautious optimism. Australian and New Zealand Journal of Psychiatry, 40, 951-962.
62. Klosterkotter, J., Ebel, H., Schultze-lutter, F., & Steinmeyer, E. M. (1996). Diagnostic validity of basic symptoms. European Archives of Psychiatry and Clinical Neurosciences, 246, 147-154.
63. Klosterkotter, J., Gross, G., Huber, G., Wieneke, A., Steinmeyer, E. M., & Schultze-lutter, F. (1997). Evaluation of the 'Bonn Scale for the Assessment of Basic Symptoms - BSABS' as an instrument for the assessment of schizophrenia proneness: A review of recent findings. Neurology, Psychiatry and Brain Research, 5, 137-150.
64. Klosterkotter, J., Hellmich, M. I., Steinmeyer, E. M., & Schultze-Lutter, F. (2001). Diagnosing schizophrenia in the initial prodromal phase. Archives of General Psychiatry, 58, 158-164.
65. Klosterkotter, J., Ruhrmann, S., Schultze-Lutter, F., Salokangas, R. K., Linszen, D., Birchwood, M. et al. (2005). The European Prediction of Psychosis Study (EPOS): Integrating early recognition and intervention in Europe. World Psychiatry, 3, 1-7.
66. Kraemer, H. C., Kazdin, A. E., Offord, D. R., Kessler, R. C., Jensen, P. S., & Kupfer, D. J. (1997). Coming to terms with the terms of risk. Archives of General Psychiatry, 54, 337-343.
67. Larsen, T. K. (2002). The transition from premorbid period to psychosis: How can it be described? Acta Psychiatrica Scandinavica, 106(Suppl.), s10-s11.
68. Larsen, T. K., Melle, I., Auestad, B., Friis, S., Haahr, U., Johannessen, J. O. et al. (2006). Early detection of first-episode psychosis: The effect on 1-year outcome. Schizophrenia Bulletin, 32, 758-764.
69. Lencz, T., Smith, C. W., Auther, A. M., Correll, C. U., & Cornblatt, B. A. (2003). The assessment of 'prodromal schizophrenia': Unresolved issues and future directions. Schizophrenia Bulletin, 29(4), 717-728.
70. Lewis, S., Tarrier, N., Haddock, G., Bentall, R., Kinderman, P., Kingdon, D. et al. (2002). Randomised controlled trial of cognitive-behavioural therapy in early schizophrenia: Acutephase outcomes. British Journal of Psychiatry, 43(Suppl.), s91-s97.
71. Malla, A. K., Norman, R. M., Manchanda, R., Ahmed, M. R., Scholten, D., Harricharan, R. et al. (2002). One year outcome in first episode psychosis: Influence of DUP and other predictors. Schizophrenia Research, 54(3), 231-242.
72. Manji, H. K., Moore, G. J., & Chen, G. (2000). Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: A role for neurotrophic and neuroprotective effects in manic depressive illness. Journal of Clinical Psychiatry, 61(Suppl. 9), s82-s96.
73. Marshall, M., Lewis, S., Lockwood, Au., Drake, R., Jones, P., & Croudace, T. (2005). Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: A systematic review. Archives of General Psychiatry, 62, 975-983.
74. Mason, O., Startup, M., Halpin, S., Schall, U., Conrad, A., & Carr, V. (2004). Risk factors for transition to first episode psychosis among individuals with 'at-risk mental states'. Schizophrenia Research, 71(2-3), 227-237.
75. McGlashan, T. H., & Johannessen, J. O. (1996). Early detection and intervention with schizophrenia: Rationale. Schizophrenia Bulletin, 22(2), 201-222.
76. McGlashan, T. H., Zipursky, R. B., Perkins, D., Addington, J., Miller, T., Woods, S. W. et al. (2006). Randomized, doubleblind trial of Olanzapine versus placebo in patients prodromally symptomatic for psychosis. American Journal of Psychiatry, 163, 790-799.
77. McGlashan, T. H., Zipursky, R. B., Perkins, D., Addington, J., Miller, T. J., Woods, S. W. et al. (2003). The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. I. Study rationale and design. Schizophrenia Research, 61(1), 7-18.
78. McGorry, P. D. (1991). Paradigm failure in functional psychosis: Review and implications. Australian and New Zealand Journal of Psychiatry, 25(1), 43-55.
79. McGorry, P. D., & Singh, B. S. (1995). Schizophrenia: Risk and possibility. In B. Raphael & G. D. Burrows (Eds.), Handbook of preventive psychiatry (pp. 492-514). Amsterdam: Elsevier.
80. McGorry, P. D., Edwards, J., Mihalopoulos, C., Harrigan, S. M., & Jackson, H. J. (1996). EPPIC: An evolving system of early detection and optimal management. Schizophrenia Bulletin, 22, 305-326.
81. McGorry, P. D., Yung, A. R., & Phillips, L. J. (2002a). 'Closing in': What features predict the onset of first-episode psychosis within an ultra-high-risk group?. In R. B. Zipursky & S. C. Schulz (Eds.) The early stages of schizophrenia (pp. 3-31). Washington, DC: American Psychiatric Publishing, Inc.
82. McGorry, P. D., Yung, A. R., Phillips, L. J., Yuen, H. P., Francey, S., Cosgrave, E. M. et al. (2002b). Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Archives of General Psychiatry, 59(10), 921-928.
83. McGorry, P. D., & Yung, A. R. (2003). Early intervention in psychosis: An overdue reform. Australian and New Zealand Journal of Psychiatry, 37(4), 393-398.
84. McGorry, P. D., Yung, A. R., & Phillips, L. J. (2003). The 'closein' or ultra high risk model: A safe and effective strategy for research and clinical intervention in prepsychotic mental disorder. Schizophrenia Bulletin, 29(4), 771-790.
85. McGorry, P. D., Hickie, I. B., Yung, A. R., Pantelis, C., & Jackson, H. J. (2006). Clinical staging of psychiatric disorders: A heuristic framework for choosing earlier, safer and more effective interventions. Australian & New Zealand Journal of Psychiatry, 40, 616-622.
86. McNaught, A.S., Jeffreys, S.E., Harvey, C.A., Quayle, A.S., King, M.B., & Bird, A.S. The Hampstead Schizophrenia Survey 1991: II. Incidence and migration near London. British Journal of Psychiatry, 170, 307-311.
87. McNeil, T. (1995). Perinatal risk factors and schizophrenia: Selective review and methodological concerns. Epidemiology Review, 17(1), 107-112.
88. McNeil, T. F., & Cantor-Graae, E. (2000). Minor physical anomalies and obstetric complications in schizophrenia. Australian & New Zealand Journal of Psychiatry, 34, S65-S73.
89. Meares, A. (1959). The diagnosis of prepsychotic schizophrenia. Lancet, i, 55-59.
90. Melle, I., Larsen, T. K., Haahr, U., Friis, S., Johannessen, J. O., Opjordsmoen, S. et al. (2004). Reducing the duration of untreated first-episode psychosis: Effects on clinical presentation. Archives of General Psychiatry, 61(2), 143-150.
91. Mihalopoulos, C., McGorry, P. D., & Carter, R. C. (1999). Is phase-specific, community-oriented treatment of early psychosis an economically viable method of improving outcome? Acta Psychiatrica Scandinavica, 100(1), 47-55.
92. Miller, T. J., McGlashan, T. H., Rosen, J. L., Somjee, L., Markovich, P. J., Stein, K. et al. (2002). Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: Preliminary evidence of interrater reliability and predictive validity. American Journal of Psychiatry, 159(5), 863-865.
93. Mojtabai, R., Malaspina, D., & Susser, E. (2003). Concepts of population prevention: Application to schizophrenia. Schizophrenia Bulletin, 29, 791-801.
94. Moller, P., & Husby, R. (2000). The initial prodrome in schizophrenia: Searching for naturalistic core dimensions of experience and behavior. Schizophrenia Bulletin, 26(1), 217-232.
95. Morrison, A. P., Bentall, R. P., French, P., Walford, L., Kilcommons, A., Knight, A. et al. (2002). Randomised controlled trial of early detection and cognitive therapy for preventing transition to psychosis in high-risk individuals. Study design and interim analysis of transition rate and psychological risk factors. British Journal of Psychiatry, 43(Suppl.), s78-s84.
96. Morrison, A. P., French, P., Walford, L., Lewis, S. W., Kilcommons, A., Green, J. et al. (2004). Cognitive therapy for the prevention of psychosis in people at ultra-high risk: Randomised controlled trial. British Journal of Psychiatry, 185, 291-297.
97. Mortensen, P. B., Pedersen, C. B., Westergaard, T., Wohlfahrt, J., Ewald, H. et al. (1999). Effects of family history and place and season of birth on the risk of schizophrenia. New England Journal of Medicine, 340, 603-608.
98. Mrazek, P. J., & Haggerty, R. J. (1994). Reducing risks for mental disorders: Frontiers for preventive intervention research. Washington DC: National Academy Press.
99. Mueser, K. T., & McGurk, S. R. (2004). Schizophrenia. The Lancet, 363, 2063-2072.
100. Murray, C., & Lopez, A. (1996). The global burden of disease. Boston: Harvard School of Public Health, WHO and World Bank.
101. Murray, C. J., Lopez, A. D., Mathers, C. D., & Stein, C. (2001). The global burden of disease 2000 project: Aims, methods and data sources. Cambridge, MA: Harvard Burden of Disease Unit.
102. Murray, R. M., & McGuffin, P. (1993). Genetic aspects of psychiatric disorders. In R. Kendell & A. Zeally (Eds.), Companion to psychiatric studies, (5th ed.) (pp. 227-261). Edinburgh: Churchill-Livingstone.
103. Nordentoft, M., Jeppesen, P., Abel, M. B., Kassow, P., Petersen, L., Thorup, A. et al. (2002). OPUS study: Suicidal behaviour, suicidal ideation and hopelessness among patients with first-episode psychosis. One-year follow-up of a randomised controlled trial. British Journal of Psychiatry, 43(Suppl.), s98-s106.
104. Offord, D. R., Kraemer, H. C., Kazdin, A. E., Jensen, P. S., & Harrington, R. (1998). Lowering the burden of suffering from child psychiatric disorder: Trade-offs among clinical, targeted, and universal interventions. Journal of the American Academy of Child & Adolescent Psychiatry, 37(7), 686-694.
105. Pantelis, C., Yucel, M., Wood, S. J., McGorry, P. D., & Velakoulis, D. (2003). Early and late neurodevelopmental disturbances in schizophrenia and their functional consequences. Australian and New Zealand Journal of Psychiatry, 37, 339-406.
106. Pantelis, C., Yucel, M., Wood, S. J., Velakoulis, D., Sun, D., Berger, G. et al. (2005). Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia. Schizophrenia Bulletin, 31, 672-696.
107. Perkins, D. O., Gu, H., Boteva, K., & Lieberman, J. A. (2005). Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: A critical review and meta-analysis. American Journal of Psychiatry, 162, 1785-1804.
108. Petersen, L., Jeppesen, P., Thorup, A., Abel, M. B., Ohlenschlaeger, J., Christensen, T. O. et al. (2005a). A randomised multicentre trial integrated versus standard treatment for patients with a first episode of psychotic illness. British Medical Journal, 331, 602-609.
109. Petersen, L., Nordentoft, M., Jeppesen, P., Ohlenschlaeger, J., Thorup, A., Christensen, T. O. et al. (2005b). Improving 1-year outcome in first-episode psychosis: OPUS trial. British Journal of Psychiatry, 48(Suppl.), s98-s103.
110. Poulton, R., Caspi, A., Moffitt, T. E., Cannon, M., Murray, R., & Harrington, H. (2000). Children's self-reported psychotic symptoms and adult schizophreniform disorder: A 15-year longitudinal study. Archives of General Psychiatry, 57(11), 1053-1058.
111. Power, P. (1999). Suicide and early psychosis. In P. D. McGorry & H. J. Jackson (Eds.), The recognition and management of early psychosis: A preventive approach (pp. 338-62). New York: Cambridge University Press.
112. Power, P. J. R., Bell, R. J., Mills, R., Herrman-Doig, T., Davern, M., Henry, L. et al. (2003). Suicide in prevention in first episode psychosis: The development of a randomised controlled trial of cognitive therapy for acutely suicidal patients with early psychosis. Australian and New Zealand Journal of Psychiatry, 37, 414-420.
113. Public Health Group. (2005). Victorian burden of disease study: Mortality and morbidity in 2001. Melbourne: Victorian Government Department of Human Services.
114. Rabinowitz, J., De Smedt, G., Harvey, P. D., & Davidson, M. (2002). Relationship between premorbid functioning and symptom severity as assessed at first episode of psychosis. American Journal of Psychiatry, 159, 2021-2026.
115. Reichenberg, A., Rabinowitz, J., Weiser, M., Mark, M., Kaplan, Z., & Davidson, M. (2000). Premorbid functioning in a national population of male twins discordant for psychoses. American Journal of Psychiatry, 157, 1514-1516.
116. Reichenberg, A., Weiser, M., Rabinowitz, J., Caspi, A., Schmeidler, J. et al. (2002). A population-based cohort study of premorbid intellectual, language, and behavioral functioning in patients with schizophrenia, schizoaffective disorder, and nonpsychotic bipolar disorder. American Journal of Psychiatry, 159, 2027-2035.
117. Rinaldi, M., McNeil, K., Firn, M., Koletsi, M., Perkins, R., & Singh, S. (2004). What are the benefits of evidence-based supported employment for patients with first-episode psychosis? Psychiatric Bulletin, 28(8), 281-284.
118. Rose, G. (1992). The strategy of preventive medicine. Oxford: Oxford University Press.
119. Ruhrmann, S., Schultze-Lutter, F., & Klosterkotter, J. (2003). Early detection and intervention in the initial prodromal phase of schizophrenia. Pharmacopsychiatry, 36(Suppl. 3), s162-s167.
120. Ruhrmann, S., Schultze-Lutter, F., Maier, W., & Klosterkotter, J. (2005). Pharmacological intervention in the initial prodromal phase of psychosis. European Psychiatry, 20(1), 1-6.
121. Ruhrmann, S., Hoppmann, B., Theysohn, S., Picker, H., Kuhn, K. U., Schultze-Lutter, F. et al. (2006). Acute symptomatic treatment effects in persons clinically at risk for psychosis. Schizophrenia Research, 86(Suppl.), s9.
122. SANE. (2002). Schizophrenia: Costs. An analysis of the burden of schizophrenia and related suicide in Australia. Sydney, Australia: SANE.
123. Schultze-Lutter, F., Wieneke, A., Picker, H., Rolff, Y., Steinmeyer, E. M., Ruhrmann, S. et al. (2004). The Schizophrenia Prediction Instrument, Adult Version (SPI-A). Schizophrenia Research, 70/1S, 76-77.
124. Spataro, J., Mullen, P. E., Burgess, P. M., Wells, D. L., & Moss, S. A. (2004). Impact of child sexual abuse on mental health: Prospective study in males and females. British Journal of Psychiatry, 184, 416-421.
125. Spauwen, J., Krabbendam, L., Lieb, R., Wittchen, H.-U., & Van Os, J. (2006). Evidence that the outcome of developmental expression of psychosis is worse for adolescents growing up in an urban environment. Psychological Medicine, 36(3), 407-415.
126. Tarrant, C. J., & Jones, P. B. (1999). The specificity of developmental precursors of schizophrenia and affective disorders. Psychiatric Annals, 29(3), 137-144.
127. Tarrier, N., Lewis, S., Haddock, G., Bentall, R., Drake, R., Kinderman, P. et al. (2004). Cognitive-behavioural therapy in first-episode and early schizophrenia. 18-month follow-up of a randomised controlled trial. British Journal of Psychiatry, 184, 231-239.
128. Thorup, A., Petersen, L., Jeppesen, P., Ohlenschlaeger, J., Christensen, T. O., Krarup, G. et al. (2005). Integrated treatment ameliorates negative symptoms in first episode psychosis - results from the Danish OPUS trial. Schizophrenia Research, 79, 95-105.
129. Tien, A. Y. (1991). Distributions of hallucinations in the population. Social Psychiatry & Psychiatric Epidemiology, 26(6), 287-292.
130. Torrey, E. F., Miller, J., Rawlings, R., & Yolken, R. H. (1997). Seasonality of births in schizophrenia and bipolar disorder: A review of the literature. Schizophrenia Research, 28, 1-38.
131. van Os, J. (2003). Is there a continuum of psychotic experiences in the general population? Epidemiologie Psichiatrica Sociale, 12(4), 242-252.
132. van Os, J. (2004). Does the urban environment cause psychosis? British Journal of Psychiatry, 184(4), 287-288.
133. van Os, J., Hanssen, M., de Graaf, R., & Vollebergh, W. (2002). Does the urban environment independently increase the risk for both negative and positive features of psychosis? Social Psychiatry & Psychiatric Epidemiology, 37(10), 460-464.
134. van Os, J., Hanssen, M., Bak, M., Bijl, R. V., & Vollebergh, W. (2003). Do urbanicity and familial liability co-participate in causing psychosis? American Journal of Psychiatry, 160, 477-482.
135. van Os, J., & McGuffin, P. (2003). Can the social environment cause schizophrenia? British Journal of Psychiatry, 182, 291-292.
136. Verdoux, H., & Cougnard, A. (2006). Schizophrenia: Who is at risk? Who is a case? International Clinical Psychopharmacology, 21(Suppl. 2), s17-s19.
137. Warner, R. (2001). The prevention of schizophrenia: What interventions are safe and effective. Schizophrenia Bulletin, 27, 551-562.
138. WHO (2001). World health report 2001: Mental health, new understanding, new hope. Geneva: World Health Organisation.
139. Wright, A., McGorry, P. D., Harris, M. G., Jorm, A. F., & Pennell, K. (2006). Development and evaluation of a youth mental health community awareness campaign - The Compass Strategy. BMC Public Health, 6, 215.
140. Wood, S. J., Berger, G. E., Lambert, M., Conus, P., Velakoulis, D., Stuart, G. W. et al. (2006). prediction of functional outcome 18 months after a first psychotic episode: A proton magnetic resonance spectroscopy study. Archives of General Psychiatry, 63, 969-976.
141. Wood, S. J., Berger, G., Velakoulis, D., Phillips, L. J., McGorry, P. D. et al. (2003). Proton magnetic resonance spectroscopy in first episode psychosis and ultra high risk individuals. Schizophrenia Bulletin, 29, 831-843.
142. Yao, J. K., Reddy, R. D., & van Kammen, D. P. (2001). Oxidative damage and schizophrenia: An overview of the evidence and its therapeutic implications. CNS Drugs, 15(4), 287-310.
143. Yung, A., McGorry, P. D., McFarlane, C. A., & Patton, G. C. (1995). The PACE clinic: Development of a clinical service for young people at high risk of psychosis. Australasian Psychiatry, 3, 345-349.
144. Yung, A. R., & McGorry, P. D. (1996). The prodromal phase of first-episode psychosis: Past and current conceptualizations. Schizophrenia Bulletin, 22(2), 353-370.
145. Yung, A. R., McGorry, P. D., McFarlane, C. A., Jackson, H. J., Patton, G. C., & Rakkar, A. (1996b). Monitoring and care of young people at incipient risk of psychosis. Schizophrenia Bulletin, 22(2), 283-303.
146. Yung, A. R., & McGorry, P. D. (1997). Is pre-psychotic intervention realistic in schizophrenia and related disorders? Australian & New Zealand Journal of Psychiatry, 31, 799-805.
147. Yung, A. R., Phillips, L. J., McGorry, P. D., McFarlane, C. A., Francey, S., Harrigan, S. M. et al. (1998). Prediction of psychosis: A step towards indicated prevention of schizophrenia. British Journal of Psychiatry, 172(Suppl. 33), s14-s20.
148. Yung, A. R., Phillips, L. J., Yuen, H. P., Francey, S. M., McFarlane, C. A., Hallgren, M. et al. (2003). Psychosis prediction: 12-month follow up of a high-risk ('prodromal') group. Schizophrenia Research, 60(1), 21-32.
149. Yung, A., & McGorry, P. (2004). Precursors of schizophrenia. Current Psychosis and Therapeutics Reports, 2, 67-72.
150. Yung, A. R., Phillips, L. J., & McGorry, P. D. (2004a). Treating schizophrenia in the prodromal phase. London: Taylor and Francis.
151. Yung, A. R., Phillips, L. J., Yuen, H. P., & McGorry, P. D. (2004b). Risk factors for psychosis in an ultra high-risk group: Psychopathology and clinical features. Schizophrenia Research, 67(2-3), 131-142.
152. Yung, A. R., Yuen, H. P., McGorry, P. D., Phillips, L. J., Kelly, D., Dell'Olio, M. et al. (2005). Mapping the onset of psychosis: The Comprehensive Assessment of At-Risk Mental States. Australian and New Zealand Journal of Psychiatry, 39(11-12), 964-971.
153. Yung, A. R., Stanford, C., Cosgrave, E., Killackey, E., Phillips, L., Nelson, B. et al. (2006). Testing the Ultra High Risk (prodromal) criteria for the prediction of psychosis in a clinical sample of young people. Schizophrenia Research, 84(1), 57-66.
154. Zammit, S., Allebeck, P., Andreasson, S., Lundberg, I., & Lewis, G. (2002). Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: Historical cohort study. British Medical Journal, 325(7374), 1199-1204.